Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Pediatr Nurs ; 34(1): 45-52, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18361086

RESUMO

Spanish speaking children with cancer were asked to describe their pain during the previous week prior to an oncology clinic appointment. Data showed that 41% of the children were experiencing pain and the overall mean pain intensity rating among these children was 5.7 +/- 2.7. Among those children with moderate to severe pain, the most frequently marked locations on the body outline diagram was the abdomen (53.8%), lower back (46.2%), and upper chest (30.8%). The higher percentage of children complaining of abdominal pain may be attributed to the high percentage (63.6%) of children reporting oral chemotherapy at home. Some children experienced pain that was unrecognized and undetected, and therefore were not receiving medications. To minimize the risk of under-treatment of pain, children and parents may be taught to use the Spanish version of the Adolescent Pediatric Pain Tool to communicate the child's pain to clinicians.


Assuntos
Atitude Frente a Saúde/etnologia , Hispânico ou Latino/etnologia , Neoplasias/complicações , Dor/diagnóstico , Dor/etnologia , Adaptação Psicológica , Recursos Audiovisuais , Criança , Barreiras de Comunicação , Estudos Transversais , Feminino , Humanos , Masculino , Multilinguismo , Neoplasias/etnologia , Avaliação em Enfermagem/métodos , Pesquisa Metodológica em Enfermagem , Dor/etiologia , Dor/prevenção & controle , Medição da Dor/métodos , Medição da Dor/enfermagem , Medição da Dor/psicologia , Psicologia da Criança , Q-Sort , Índice de Gravidade de Doença , Inquéritos e Questionários , Texas/epidemiologia , Tradução
2.
Oncol Nurs Forum ; 42(4): E287-93, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26148325

RESUMO

PURPOSE/OBJECTIVES: To describe the trajectories of obesity/overweight rates by age group among survivors of childhood acute lymphoblastic leukemia (ALL) from diagnosis through several years post-therapy. DESIGN: Longitudinal, descriptive. SETTING: Hematology/oncology clinic in the southwestern United States. SAMPLE: 62 child and adolescent ALL survivors receiving treatment and follow-up care from 1999-2013. METHODS: Retrospective chart review of height, weight, and body mass index. MAIN RESEARCH VARIABLES: Annual obesity/overweight rates and developmental age groups. FINDINGS: Different trajectories of obesity/overweight rates existed among age groups. Forty-seven percent of adolescents met the Centers for Disease Control and Prevention criteria for obesity/overweight status at some point following diagnosis, compared to 68% of school-age and 73% of preschool children. Preschool children demonstrated the most rapid rate increase following diagnosis, with a particularly susceptible period in the years immediately following therapy. Obesity/overweight persistence was most characteristic of school-age children. CONCLUSIONS: Important variations in rate and pattern of weight status trajectories exist by age group, demonstrating that children diagnosed with ALL during the preschool and school-age developmental years have the greatest vulnerability of developing obesity/overweight status. IMPLICATIONS FOR NURSING: Obesity/overweight prevention efforts are greatly needed in children with ALL, and efforts should occur before ALL treatment completion in preschool and school-age children.


Assuntos
Antineoplásicos/efeitos adversos , Antineoplásicos/uso terapêutico , Peso Corporal/efeitos dos fármacos , Obesidade/etiologia , Obesidade Infantil/etiologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicações , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Adolescente , Fatores Etários , Índice de Massa Corporal , Criança , Pré-Escolar , Feminino , Humanos , Estudos Longitudinais , Masculino , Estudos Retrospectivos , Sudoeste dos Estados Unidos , Sobreviventes
3.
J Pediatr Oncol Nurs ; 29(1): 5-13, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22367765

RESUMO

A major children's cancer and hematology center established a Quality Transformation (QT) Core to develop and monitor empirical outcomes that demonstrate excellence in clinical care. The QT Core, based on the Institute of Medicine's domains of quality health care, aims to ensure that care is safe, effective, patient centered, timely, efficient, and equitable. Specific goals for the first year of the QT Core were to develop a team of improvement science experts, engage faculty and staff in QT initiatives, promote accountability for excellence in clinical care, and establish specific metrics to evaluate process, structure, and outcomes for QT Core projects. The purpose of this article is to discuss the successful development of a quality transformation core within a pediatric subspecialty and demonstrate the principles of improvement science through an actual quality transformation project designed to implement an evidence-based guideline for procedural sedation for children with cancer. The QT Core within this subspecialty was founded on principles of successful transformation of patient care that includes motivation to change, leaders committed to quality, active engagement of staff in meaningful problem-solving initiatives, alignment with organization goals with resource allocation, and integration to bridge boundaries throughout an organization. These key principles are demonstrated through the discussion of the development of the QT Core and implementation of an evidence-based procedure sedation guideline. Pediatric and pediatric subspecialty groups can be on the forefront of national initiatives that promote quality health care, exemplified by the QT Core developed within the cancer and hematology center.


Assuntos
Institutos de Câncer/organização & administração , Sedação Consciente/métodos , Medicina Baseada em Evidências , Hematologia/organização & administração , Pediatria/organização & administração , Garantia da Qualidade dos Cuidados de Saúde/organização & administração , Melhoria de Qualidade/organização & administração , Institutos de Câncer/normas , Criança , Hematologia/normas , Humanos , Neoplasias/terapia , Pediatria/normas , Guias de Prática Clínica como Assunto
4.
Cancer ; 110(10): 2321-30, 2007 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-17926333

RESUMO

BACKGROUND: Dexamethasone improves the cure rate of childhood acute lymphoblastic leukemia (ALL) but causes physical and behavioral adverse events. The objective of the current study was to determine the effect of dexamethasone exposure on sleep and fatigue in pediatric patients with ALL. METHODS: One hundred pediatric patients with low-risk or standard-risk ALL were enrolled on 1 of 3 protocols (St. Jude Total XV, Children's Oncology Group [COG] 9904, or COG 9905) at 3 institutions. The mean age of the cohort was 9.24 +/- 3.23 years (range, 5.03-18.14 years). The majority of patients were white (79%) males (62%) with standard-risk ALL (63%). The cohort was divided into 4 subgroups: St. Jude low-risk, St. Jude standard-risk, COG low-risk, and COG standard-risk. Patients wore a wrist actigraph to monitor sleep activity during 2 consecutive 5-day periods: During the first period, they did not receive dexamethasone; and, during the second period, they did. Patients and their parents completed fatigue instruments on Days 2 and 5 of each period, and parents completed sleep diaries. RESULTS: Actual sleep minutes, sleep duration, total daily nap minutes, and fatigue increased significantly during the dexamethasone treatment for 3 to 4 of the subgroups. Total daily nap minutes increased significantly for both standard-risk groups during the dexamethasone treatment. Parents reported significant increases in their child's nighttime awakenings, restless sleep, and nap time during dexamethasone treatment. CONCLUSIONS: Dexamethasone treatment during continuation therapy for childhood ALL significantly and adversely altered sleep and fatigue, confirming that sleep and fatigue are behavioral responses to dexamethasone.


Assuntos
Antineoplásicos/efeitos adversos , Dexametasona/efeitos adversos , Fadiga/induzido quimicamente , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Sono/efeitos dos fármacos , Adolescente , Antineoplásicos/uso terapêutico , Criança , Pré-Escolar , Dexametasona/uso terapêutico , Feminino , Humanos , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA